Congress leaders have raised concerns over India’s drug regulator granting permission for the restricted use of Bharat Biotech's Covaxin and asked the government to explain why mandatory protocols and verification of data has been dispensed with. Congress MP Shashi Tharoor warned against the use of Covaxin. Watch the video to know more.